Roth Capital Forecasts Aspen Aerogels Q1 Earnings

Aspen Aerogels, Inc. (NYSE:ASPN) – Equities researchers at Roth Capital issued their Q1 2025 earnings per share (EPS) estimates for shares of Aspen Aerogels in a research note issued on Thursday, October 17th. Roth Capital analyst C. Moore forecasts that the construction company will post earnings per share of $0.02 for the quarter. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.21 per share. Roth Capital also issued estimates for Aspen Aerogels’ Q2 2025 earnings at $0.05 EPS, Q3 2025 earnings at $0.18 EPS, FY2025 earnings at $0.50 EPS and FY2026 earnings at $1.00 EPS.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The firm had revenue of $117.80 million for the quarter, compared to analysts’ expectations of $101.99 million. During the same quarter last year, the business posted ($0.22) earnings per share. The company’s revenue for the quarter was up 144.4% compared to the same quarter last year.

Other equities research analysts have also recently issued reports about the company. B. Riley raised Aspen Aerogels to a “strong-buy” rating in a report on Tuesday, June 25th. TD Cowen lifted their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. Benchmark reiterated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a research report on Thursday, August 8th. Roth Mkm reissued a “buy” rating and issued a $36.00 target price on shares of Aspen Aerogels in a report on Wednesday, August 21st. Finally, HC Wainwright reaffirmed a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $29.70.

Aspen Aerogels Stock Down 3.7 %

Shares of ASPN stock opened at $21.60 on Friday. The company’s fifty day simple moving average is $26.00 and its two-hundred day simple moving average is $24.40. Aspen Aerogels has a 52 week low of $6.62 and a 52 week high of $33.15. The stock has a market cap of $1.65 billion, a P/E ratio of -49.09 and a beta of 2.16. The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23.

Institutional Trading of Aspen Aerogels

Several institutional investors and hedge funds have recently modified their holdings of the stock. GSA Capital Partners LLP bought a new position in shares of Aspen Aerogels during the first quarter valued at approximately $1,181,000. Oppenheimer & Co. Inc. purchased a new position in shares of Aspen Aerogels in the 1st quarter valued at $388,000. Comerica Bank bought a new position in shares of Aspen Aerogels in the 1st quarter worth $1,992,000. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of Aspen Aerogels by 66.7% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 80,591 shares of the construction company’s stock worth $1,922,000 after purchasing an additional 32,243 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in Aspen Aerogels by 5.1% during the first quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after purchasing an additional 175,906 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Insider Activity at Aspen Aerogels

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at $14,523,709.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.